A citation-based method for searching scientific literature

Muhammad Usman Rashid, Noor Muhammad, Seerat Bajwa, Saima Faisal, Muhammad Tahseen, Justo Lorenzo Bermejo, Asim Amin, Asif Loya, Ute Hamann. BMC Cancer 2016
Times Cited: 13







List of co-cited articles
27 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Prevalence of BRCA1 and BRCA2 mutations in Pakistani breast and ovarian cancer patients.
Muhammad U Rashid, Anbreen Zaidi, Diana Torres, Faisal Sultan, Axel Benner, Bilal Naqvi, Abdul R Shakoori, Antje Seidel-Renkert, Humirah Farooq, Steven Narod,[...]. Int J Cancer 2006
72
38

Association between the BsmI Polymorphism in the Vitamin D Receptor Gene and Breast Cancer Risk: Results from a Pakistani Case-Control Study.
Muhammad Usman Rashid, Merium Muzaffar, Faiz Ali Khan, Maria Kabisch, Noor Muhammad, Sabeen Faiz, Asif Loya, Ute Hamann. PLoS One 2015
20
30

Deleterious RAD51C germline mutations rarely predispose to breast and ovarian cancer in Pakistan.
Muhammad U Rashid, Noor Muhammad, Saima Faisal, Asim Amin, Ute Hamann. Breast Cancer Res Treat 2014
17
23

Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology.
Sue Richards, Nazneen Aziz, Sherri Bale, David Bick, Soma Das, Julie Gastier-Foster, Wayne W Grody, Madhuri Hegde, Elaine Lyon, Elaine Spector,[...]. Genet Med 2015
23

Large genomic rearrangements in the familial breast and ovarian cancer gene BRCA1 are associated with an increased frequency of high risk features.
Paul A James, Sarah Sawyer, Samantha Boyle, Mary-Anne Young, Serguei Kovalenko, Rebecca Doherty, Joanne McKinley, Kathryn Alsop, Victoria Beshay, Marion Harris,[...]. Fam Cancer 2015
16
15

Low frequency of large genomic rearrangements of BRCA1 and BRCA2 in western Denmark.
Mads Thomassen, Anne-Marie Gerdes, Dorthe Cruger, Peter K A Jensen, Torben A Kruse. Cancer Genet Cytogenet 2006
40
15

BRCA1 and BRCA2 germline mutation analysis in the Indonesian population.
Dewajani Purnomosari, Gerard Pals, Artanto Wahyono, Teguh Aryandono, Tjakra W Manuaba, Samuel J Haryono, Paul J van Diest. Breast Cancer Res Treat 2007
25
15

Large BRCA1 and BRCA2 genomic rearrangements in Malaysian high risk breast-ovarian cancer families.
Peter Kang, Shivaani Mariapun, Sze Yee Phuah, Linda Shushan Lim, Jianjun Liu, Sook-Yee Yoon, Meow Keong Thong, Nur Aishah Mohd Taib, Cheng Har Yip, Soo-Hwang Teo. Breast Cancer Res Treat 2010
32
15

Identification of the breast cancer susceptibility gene BRCA2.
R Wooster, G Bignell, J Lancaster, S Swift, S Seal, J Mangion, N Collins, S Gregory, C Gumbs, G Micklem. Nature 1995
15

A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1.
Y Miki, J Swensen, D Shattuck-Eidens, P A Futreal, K Harshman, S Tavtigian, Q Liu, C Cochran, L M Bennett, W Ding. Science 1994
15

Significant clinical impact of recurrent BRCA1 and BRCA2 mutations in Mexico.
Cynthia Villarreal-Garza, Rosa María Alvarez-Gómez, Carlos Pérez-Plasencia, Luis A Herrera, Josef Herzog, Danielle Castillo, Alejandro Mohar, Clementina Castro, Lenny N Gallardo, Dolores Gallardo,[...]. Cancer 2015
55
15

Heterogeneity of triple-negative breast cancer: histologic subtyping to inform the outcome.
Emilia Montagna, Patrick Maisonneuve, Nicole Rotmensz, Giuseppe Cancello, Monica Iorfida, Alessandra Balduzzi, Viviana Galimberti, Paolo Veronesi, Alberto Luini, Giancarlo Pruneri,[...]. Clin Breast Cancer 2013
83
15

Clinicopathologic features of triple negative breast cancers: an experience from Pakistan.
Atif Ali Hashmi, Muhammad Muzzammil Edhi, Hanna Naqvi, Naveen Faridi, Amna Khurshid, Mehmood Khan. Diagn Pathol 2014
25
15

Epidemiology, biology, and treatment of triple-negative breast cancer in women of African ancestry.
Abenaa M Brewster, Mariana Chavez-MacGregor, Powel Brown. Lancet Oncol 2014
119
15

Inherited mutations in 17 breast cancer susceptibility genes among a large triple-negative breast cancer cohort unselected for family history of breast cancer.
Fergus J Couch, Steven N Hart, Priyanka Sharma, Amanda Ewart Toland, Xianshu Wang, Penelope Miron, Janet E Olson, Andrew K Godwin, V Shane Pankratz, Curtis Olswold,[...]. J Clin Oncol 2015
360
15

Constitutional CHEK2 mutations are infrequent in early-onset and familial breast/ovarian cancer patients from Pakistan.
Muhammad U Rashid, Noor Muhammad, Saima Faisal, Asim Amin, Ute Hamann. BMC Cancer 2013
15
15

Prevalence of PALB2 mutations in Australian familial breast cancer cases and controls.
Ella R Thompson, Kylie L Gorringe, Simone M Rowley, Michelle W Wong-Brown, Simone McInerny, Na Li, Alison H Trainer, Lisa Devereux, Maria A Doyle, Jason Li,[...]. Breast Cancer Res 2015
24
15

Prevalence of TP53 germ line mutations in young Pakistani breast cancer patients.
Muhammad U Rashid, Sidra Gull, Kashif Asghar, Noor Muhammad, Asim Amin, Ute Hamann. Fam Cancer 2012
12
16

Association of PALB2 sequence variants with the risk of familial and early-onset breast cancer in a South-American population.
Yessica Leyton, Patricio Gonzalez-Hormazabal, Rafael Blanco, Teresa Bravo, Ricardo Fernandez-Ramires, Sebastian Morales, Natalia Landeros, Jose M Reyes, Octavio Peralta, Julio C Tapia,[...]. BMC Cancer 2015
13
15

Gene panel sequencing in familial breast/ovarian cancer patients identifies multiple novel mutations also in genes others than BRCA1/2.
Cornelia Kraus, Juliane Hoyer, Georgia Vasileiou, Marius Wunderle, Michael P Lux, Peter A Fasching, Mandy Krumbiegel, Steffen Uebe, Miriam Reuter, Matthias W Beckmann,[...]. Int J Cancer 2017
60
15

Novel and recurrent BRCA1/BRCA2 mutations in early onset and familial breast and ovarian cancer detected in the Program of Genetic Counseling in Cancer of Valencian Community (eastern Spain). Relationship of family phenotypes with mutation prevalence.
Inmaculada de Juan Jiménez, Zaida García Casado, Sarai Palanca Suela, Eva Esteban Cardeñosa, José Antonio López Guerrero, Ángel Segura Huerta, Isabel Chirivella González, Ana Beatriz Sánchez Heras, Ma José Juan Fita, Isabel Tena García,[...]. Fam Cancer 2013
21
15


Genetic/Familial High-Risk Assessment: Breast and Ovarian, Version 2.2015.
Mary B Daly, Robert Pilarski, Jennifer E Axilbund, Michael Berry, Saundra S Buys, Beth Crawford, Meagan Farmer, Susan Friedman, Judy E Garber, Seema Khan,[...]. J Natl Compr Canc Netw 2016
111
15

Contribution of BRCA1 and BRCA2 mutations to breast and ovarian cancer in Pakistan.
Alexander Liede, Imtiaz A Malik, Zeba Aziz, Patricia de los Rios Pd, Elaine Kwan, Steven A Narod. Am J Hum Genet 2002
100
15

Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries.
Freddie Bray, Jacques Ferlay, Isabelle Soerjomataram, Rebecca L Siegel, Lindsey A Torre, Ahmedin Jemal. CA Cancer J Clin 2018
15

PARP inhibitors: Synthetic lethality in the clinic.
Christopher J Lord, Alan Ashworth. Science 2017
846
15

Risks of Breast, Ovarian, and Contralateral Breast Cancer for BRCA1 and BRCA2 Mutation Carriers.
Karoline B Kuchenbaecker, John L Hopper, Daniel R Barnes, Kelly-Anne Phillips, Thea M Mooij, Marie-José Roos-Blom, Sarah Jervis, Flora E van Leeuwen, Roger L Milne, Nadine Andrieu,[...]. JAMA 2017
803
15

Prevalence of BRCA1 genomic rearrangements in a large cohort of Italian breast and breast/ovarian cancer families without detectable BRCA1 and BRCA2 point mutations.
Simona Agata, Alessandra Viel, Lara Della Puppa, Laura Cortesi, Giusi Fersini, Monia Callegaro, Maurizia Dalla Palma, Riccardo Dolcetti, Massimo Federico, Salvatore Venuta,[...]. Genes Chromosomes Cancer 2006
45
7

Distinct BRCA1 rearrangements involving the BRCA1 pseudogene suggest the existence of a recombination hot spot.
Nadine Puget, Sophie Gad, Laure Perrin-Vidoz, Olga M Sinilnikova, Dominique Stoppa-Lyonnet, Gilbert M Lenoir, Sylvie Mazoyer. Am J Hum Genet 2002
75
7

MLPA screening in the BRCA1 gene from 1,506 German hereditary breast cancer cases: novel deletions, frequent involvement of exon 17, and occurrence in single early-onset cases.
Stefanie Engert, Barbara Wappenschmidt, Beate Betz, Karin Kast, Michael Kutsche, Heide Hellebrand, Timm O Goecke, Marion Kiechle, Dieter Niederacher, Rita K Schmutzler,[...]. Hum Mutat 2008
69
7

Analysis of BRCA1and BRCA2 large genomic rearrangements in Sri Lankan familial breast cancer patients and at risk individuals.
Sumadee De Silva, Kamani Hemamala Tennekoon, Eric Hamilton Karunanayake, Indrani Amarasinghe, Preethika Angunawela. BMC Res Notes 2014
5
20

Deletion of exons 1a-2 of BRCA1: a rather frequent pathogenic abnormality.
Ans M W van den Ouweland, Winand N M Dinjens, Lambert C J Dorssers, Monique M van Veghel-Plandsoen, Hennie T Brüggenwirth, Caroline J Withagen-Hermans, Johanna Margriet Collée, Simon A Joosse, Joan N R Terlouw-Kromosoeto, Petra M Nederlof. Genet Test Mol Biomarkers 2009
16
7

Significant contribution of germline BRCA2 rearrangements in male breast cancer families.
Isabelle Tournier, Brigitte Bressac-de Paillerets, Hagay Sobol, Dominique Stoppa-Lyonnet, Rosette Lidereau, Michel Barrois, Sylvie Mazoyer, Florence Coulet, Agnès Hardouin, Agnès Chompret,[...]. Cancer Res 2004
80
7

Gross rearrangements in BRCA1 but not BRCA2 play a notable role in predisposition to breast and ovarian cancer in high-risk families of German origin.
Sabine Preisler-Adams, Ines Schönbuchner, Britta Fiebig, Brigitte Welling, Bernd Dworniczak, Bernhard H F Weber. Cancer Genet Cytogenet 2006
43
7

BRCA1 and BRCA2 point mutations and large rearrangements in breast and ovarian cancer families in Northern Poland.
Magdalena Ratajska, Izabela Brozek, Elzbieta Senkus-Konefka, Jacek Jassem, Magdalena Stepnowska, Grazia Palomba, Marina Pisano, Milena Casula, Giuseppe Palmieri, Ake Borg,[...]. Oncol Rep 2008
50
7

Assessment of individuals with BRCA1 and BRCA2 large rearrangements in high-risk breast and ovarian cancer families.
Angela G Arnold, Ebunoluwa Otegbeye, Megan Harlan Fleischut, Emily A Glogowski, Beth Siegel, Sherry R Boyar, Erin Salo-Mullen, Kim Amoroso, Margaret Sheehan, Janice L Berliner,[...]. Breast Cancer Res Treat 2014
7
14

Triple negative tumours: a critical review.
J S Reis-Filho, A N J Tutt. Histopathology 2008
629
7

BRCA1 genomic deletions are major founder mutations in Dutch breast cancer patients.
A Petrij-Bosch, T Peelen, M van Vliet, R van Eijk, R Olmer, M Drüsedau, F B Hogervorst, S Hageman, P J Arts, M J Ligtenberg,[...]. Nat Genet 1997
348
7

Genomic large rearrangement screening of BRCA1 and BRCA2 genes in high-risk Turkish breast/ovarian cancer patients by using multiplex ligation-dependent probe amplification assay.
Esra Manguoğlu, Sefik Güran, Deniz Yamaç, Mehmet Simşek, Selime Akdeniz, Taner Colak, Hakan Gülkesen, Güven Lüleci. Cancer Invest 2011
5
20

Large BRCA1 and BRCA2 genomic rearrangements in Polish high-risk breast and ovarian cancer families.
Helena Rudnicka, Tadeusz Debniak, Cezary Cybulski, Tomasz Huzarski, Jacek Gronwald, Jan Lubinski, Bohdan Gorski. Mol Biol Rep 2013
12
8

Large genomic rearrangement in BRCA1 and BRCA2 and clinical characteristics of men with breast cancer in the United States.
Julia Tchou, M Renee Ward, Patricia Volpe, Maurizia Dalla Palma, C Angelina Medina, Michael Sargen, Seema S Sonnad, Andrew K Godwin, Mary Daly, David J Winchester,[...]. Clin Breast Cancer 2007
1
100

Large genomic deletions and duplications in the BRCA1 gene identified by a novel quantitative method.
Frans B L Hogervorst, Petra M Nederlof, Johan J P Gille, Cathal J McElgunn, Maartje Grippeling, Roelof Pruntel, Rein Regnerus, Tibor van Welsem, Resie van Spaendonk, Fred H Menko,[...]. Cancer Res 2003
255
7

Large BRCA1 and BRCA2 genomic rearrangements in Danish high risk breast-ovarian cancer families.
Thomas v O Hansen, Lars Jønson, Anders Albrechtsen, Mette K Andersen, Bent Ejlertsen, Finn C Nielsen. Breast Cancer Res Treat 2009
50
7

A multi-institutional study of the prevalence of BRCA1 and BRCA2 large genomic rearrangements in familial breast cancer patients.
Moon-Woo Seong, Sung Im Cho, Kyu Hyung Kim, Il Yong Chung, Eunyoung Kang, Jong Won Lee, Sue K Park, Min Hyuk Lee, Doo Ho Choi, Cha Kyong Yom,[...]. BMC Cancer 2014
20
7

Screening for genomic rearrangements in BRCA1 and BRCA2 genes in Czech high-risk breast/ovarian cancer patients: high proportion of population specific alterations in BRCA1 gene.
Ivana Ticha, Zdenek Kleibl, Jana Stribrna, Jaroslav Kotlas, Martina Zimovjanova, Martin Mateju, Michal Zikan, Petr Pohlreich. Breast Cancer Res Treat 2010
32
7

Contribution of BRCA1 and BRCA2 mutations to inherited ovarian cancer.
Susan J Ramus, Patricia A Harrington, Carole Pye, Richard A DiCioccio, Mark J Cox, Kim Garlinghouse-Jones, Ingrid Oakley-Girvan, Ian J Jacobs, Richard M Hardy, Alice S Whittemore,[...]. Hum Mutat 2007
57
7

The relative contribution of point mutations and genomic rearrangements in BRCA1 and BRCA2 in high-risk breast cancer families.
Maurizia Dalla Palma, Susan M Domchek, Jill Stopfer, Julie Erlichman, Jill D Siegfried, Jessica Tigges-Cardwell, Bernard A Mason, Timothy R Rebbeck, Katherine L Nathanson. Cancer Res 2008
76
7


Complete genomic sequence and analysis of 117 kb of human DNA containing the gene BRCA1.
T M Smith, M K Lee, C I Szabo, N Jerome, M McEuen, M Taylor, L Hood, M C King. Genome Res 1996
223
7

Genetic heterogeneity and penetrance analysis of the BRCA1 and BRCA2 genes in breast cancer families. The Breast Cancer Linkage Consortium.
D Ford, D F Easton, M Stratton, S Narod, D Goldgar, P Devilee, D T Bishop, B Weber, G Lenoir, J Chang-Claude,[...]. Am J Hum Genet 1998
7


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.